MENU
+Compare
TNGX
Stock ticker: NASDAQ
AS OF
Sep 16, 04:34 PM (EDT)
Price
$7.32
Change
+$0.50 (+7.33%)
Capitalization
758.79M

TNGX Tango Therapeutics Forecast, Technical & Fundamental Analysis

Tango Therapeutics Inc is a biotechnology company... Show more

TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TNGX with price predictions
Sep 15, 2025

TNGX sees its Stochastic Oscillator climbs out of oversold territory

On September 15, 2025, the Stochastic Oscillator for TNGX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 62 instances where the indicator left the oversold zone. In of the 62 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 15, 2025. You may want to consider a long position or call options on TNGX as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

TNGX moved above its 50-day moving average on September 15, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TNGX advanced for three days, in of 275 cases, the price rose further within the following month. The odds of a continued upward trend are .

TNGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TNGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.621) is normal, around the industry mean (20.594). P/E Ratio (0.000) is within average values for comparable stocks, (53.282). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.156). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (30.960) is also within normal values, averaging (342.112).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TNGX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TNGX is expected to report earnings to fall 79.46% to -7 cents per share on November 05

Tango Therapeutics TNGX Stock Earnings Reports
Q3'25
Est.
$-0.07
Q2'25
Est.
$-0.35
Q1'25
Est.
$-0.36
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.10
The last earnings report on August 05 showed earnings per share of -34 cents, meeting the estimate of -34 cents. With 1.95M shares outstanding, the current market capitalization sits at 758.79M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 857 320-4900
Employees
140
Web
https://www.tangotx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWEIX9.02N/A
N/A
American Century Equity Income Inv
GRMRX30.40N/A
N/A
Nationwide S&P 500 Index R
INRSX19.28N/A
N/A
Macquarie Natural Resources R6
MXTFX6.99N/A
N/A
Empower Small Cap Value Instl
ESIGX13.14N/A
N/A
Ashmore Emerging Markets Equity ESG Ins

TNGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
+4.44%
AXON - TNGX
41%
Loosely correlated
+0.62%
MDGL - TNGX
39%
Loosely correlated
-1.53%
IMTX - TNGX
37%
Loosely correlated
-2.06%
FDMT - TNGX
37%
Loosely correlated
-0.15%
BNTC - TNGX
36%
Loosely correlated
-1.08%
More